Oxford Cannabinoid Technologies Holdings Plc (LON:OCTP – Get Free Report)’s stock price dropped 1.4% during trading on Tuesday . The company traded as low as GBX 0.34 ($0.00) and last traded at GBX 0.36 ($0.00). Approximately 8,511,182 shares changed hands during trading, an increase of 58% from the average daily volume of 5,381,615 shares. The stock had previously closed at GBX 0.37 ($0.00).
Oxford Cannabinoid Technologies Trading Down 1.4 %
The stock’s fifty day moving average is GBX 0.41 and its 200 day moving average is GBX 0.59. The company has a market capitalization of £3.92 million, a P/E ratio of -53.10 and a beta of 0.79.
About Oxford Cannabinoid Technologies
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions.
Recommended Stories
- Five stocks we like better than Oxford Cannabinoid Technologies
- Quiet Period Expirations Explained
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- What is the S&P 500 and How It is Distinct from Other Indexes
- Hilton Demonstrates Asset Light is Right for Investors
- The “How” and “Why” of Investing in 5G Stocks
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Oxford Cannabinoid Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Cannabinoid Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
